Smart-Money SignalDistribution · 42/100— Insiders are net sellers over 90 days (-$3.4M, 4 sales vs 2 buys)
Revenue$628.7M
Net Income$212.1M
EPS$1.60
Market Cap$13.6B
Price Performance
Historical data including institutional events
Company Profile
M
Michael M. Morrissey
CEO & Executive Director
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
